tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market

Ascletis Pharma, Inc. (1672) Income Statement

Compare
8 Followers

Ascletis Pharma, Inc. Income Statement

Last quarter (Q2 2025), Ascletis Pharma, Inc.'s total revenue was ¥1.08M, a decrease of -97.68% from the same quarter last year. In Q2, Ascletis Pharma, Inc.'s net income was ¥-87.95M. See Ascletis Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.28M¥ 56.60M¥ 54.09M¥ 76.88M¥ 35.00M
Gross Profit
¥ 735.00K¥ 25.99M¥ -24.69M¥ 39.17M¥ -23.50M
Operating Expenses
¥ 296.15M¥ 150.29M¥ 319.29M¥ 264.14M¥ 129.44M
Depreciation and Amortization
¥ 14.18M¥ 18.48M¥ 30.19M¥ 29.55M¥ 27.16M
EBITDA
¥ -390.45M¥ -126.09M¥ -284.50M¥ -169.35M¥ -181.94M
Operating Income
¥ -295.42M¥ -300.21M¥ -343.98M¥ -224.97M¥ -217.11M
Other Income/Expenses
¥ -5.52M¥ 0.00¥ 29.13M¥ 25.95M¥ 7.87M
Pretax Income
¥ -300.94M¥ -144.72M¥ -314.84M¥ -199.02M¥ -209.24M
Net Income
¥ -300.94M¥ -144.72M¥ -314.84M¥ -199.02M¥ -209.24M
Per Share Metrics
Basic EPS
¥ -0.30¥ -0.13¥ -0.29¥ -0.18¥ -0.20
Diluted EPS
¥ -0.30¥ -0.13¥ -0.29¥ -0.18¥ -0.20
Weighted Average Shares Outstanding
1.00B 1.07B 1.09B 1.10B 1.04B
Weighted Average Shares Outstanding (Diluted)
1.00B 1.07B 1.09B 1.10B 1.04B
Currency in CNY

Ascletis Pharma, Inc. Earnings and Revenue History